Healthcare Common Procedure Coding System codes
HCPCS Temporary Codes codes
Look up any HCPCS code in the Q0035-Q9992 range, or search every CPT, HCPCS, DRG, revenue, and drug code at once. Open a code to compare its fee schedules and payer-negotiated rates.
- Codes in this category
- 580
- HCPCS categories
- 31
- Code systems
- 6
Temporary Codes
HCPCS Q0035-Q9992
Showing 81-100 of 580 codes
- Q2035Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Afluria)View rates
- Q2036Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Flulaval)View rates
- Q2037Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluvirin)View rates
- Q2038Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluzone)View rates
- Q2039Influenza virus vaccine, not otherwise specifiedView rates
- Q2041Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2042Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2043Sipuleucel-T, minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, including leukapheresis and all other preparatory procedures, per infusionView rates
- Q2049Injection, doxorubicin hydrochloride, liposomal, imported Lipodox, 10 mgView rates
- Q2050Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mgView rates
- Q2052Services, supplies, and accessories used in the home for the administration of intravenous immune globulin (ivig)View rates
- Q2053Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2054Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2055Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2056Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2057Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic doseView rates
- Q2058Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusionView rates
- Q3001Radioelements for brachytherapy, any type, eachView rates
- Q3014Telehealth originating site facility feeView rates
- Q3027Injection, interferon beta-1a, 1 mcg for intramuscular useView rates